
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Heart failure—emerging roles for the mitochondrial pyruvate carrier
Mariana Fernández-Caggiano, Philip Eaton
Cell Death and Differentiation (2021) Vol. 28, Iss. 4, pp. 1149-1158
Open Access | Times Cited: 36
Mariana Fernández-Caggiano, Philip Eaton
Cell Death and Differentiation (2021) Vol. 28, Iss. 4, pp. 1149-1158
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Hypoxia-induced signaling in the cardiovascular system: pathogenesis and therapeutic targets
Yongchao Zhao, Weidong Xiong, Chaofu Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 102
Yongchao Zhao, Weidong Xiong, Chaofu Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 102
The impact of oxidative stress-induced mitochondrial dysfunction on diabetic microvascular complications
Ziwei Zhang, Qingxia Huang, Daqing Zhao, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 83
Ziwei Zhang, Qingxia Huang, Daqing Zhao, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 83
Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis
Yulan Ma, Chun‐Yan Kong, Zhen Guo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Yulan Ma, Chun‐Yan Kong, Zhen Guo, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Lactate and lactylation in cardiovascular diseases: current progress and future perspectives
Wengen Zhu, Siyu Guo, Junyi Sun, et al.
Metabolism (2024) Vol. 158, pp. 155957-155957
Closed Access | Times Cited: 17
Wengen Zhu, Siyu Guo, Junyi Sun, et al.
Metabolism (2024) Vol. 158, pp. 155957-155957
Closed Access | Times Cited: 17
Pyruvate plus uridine augment mitochondrial respiration and prevent cardiac hypertrophy in zebrafish and H9c2 cells
Soumyajit Mukherjee, Shreya Das, Surajit Das, et al.
Journal of Cell Science (2025) Vol. 138, Iss. 9
Open Access | Times Cited: 2
Soumyajit Mukherjee, Shreya Das, Surajit Das, et al.
Journal of Cell Science (2025) Vol. 138, Iss. 9
Open Access | Times Cited: 2
Immunometabolic mechanisms of heart failure with preserved ejection fraction
Gabriele G. Schiattarella, Pilar Alcaide, Gianluigi Condorelli, et al.
Nature Cardiovascular Research (2022) Vol. 1, Iss. 3, pp. 211-222
Open Access | Times Cited: 67
Gabriele G. Schiattarella, Pilar Alcaide, Gianluigi Condorelli, et al.
Nature Cardiovascular Research (2022) Vol. 1, Iss. 3, pp. 211-222
Open Access | Times Cited: 67
Targeting Lactic Acid Modification in Ischemic Heart Diseases: Novel Therapeutics and Mechanism
Ting Wan, Yucheng Liang, Tianwen Wei, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access | Times Cited: 1
Ting Wan, Yucheng Liang, Tianwen Wei, et al.
Journal of Cardiovascular Translational Research (2025)
Closed Access | Times Cited: 1
Interspecies differences in mitochondria: Implications for cardiac and vascular translational research
Lisa Alibrandi, Vincenzo Lionetti
Vascular Pharmacology (2025), pp. 107476-107476
Closed Access | Times Cited: 1
Lisa Alibrandi, Vincenzo Lionetti
Vascular Pharmacology (2025), pp. 107476-107476
Closed Access | Times Cited: 1
The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism
Nicole K.H. Yiew, Brian N. Finck
AJP Endocrinology and Metabolism (2022) Vol. 323, Iss. 1, pp. E33-E52
Open Access | Times Cited: 38
Nicole K.H. Yiew, Brian N. Finck
AJP Endocrinology and Metabolism (2022) Vol. 323, Iss. 1, pp. E33-E52
Open Access | Times Cited: 38
Targeting mitochondrial impairment for the treatment of cardiovascular diseases: From hypertension to ischemia-reperfusion injury, searching for new pharmacological targets
Simona Todisco, Biagia Musio, Vito Pesce, et al.
Biochemical Pharmacology (2023) Vol. 208, pp. 115405-115405
Closed Access | Times Cited: 14
Simona Todisco, Biagia Musio, Vito Pesce, et al.
Biochemical Pharmacology (2023) Vol. 208, pp. 115405-115405
Closed Access | Times Cited: 14
Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin
Paula López-Vázquez, Mariana Fernández-Caggiano, Eduardo Barge‐Caballero, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Paula López-Vázquez, Mariana Fernández-Caggiano, Eduardo Barge‐Caballero, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Pathogenic mitochondrial dysfunction and metabolic abnormalities
Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114809-114809
Open Access | Times Cited: 31
Walter H. Moos, Douglas V. Faller, Ioannis P. Glavas, et al.
Biochemical Pharmacology (2021) Vol. 193, pp. 114809-114809
Open Access | Times Cited: 31
Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression
Yu Zhao, Zongshi Lu, Hexuan Zhang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Yu Zhao, Zongshi Lu, Hexuan Zhang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 4
Cardioprotective Effects of Jiming Formula on Improving Myocardial Metabolism in Mice with Myocardial Infarction Via the Ampk/Sirt1/Pgc-1α Pathway
Xinyi Fan, Xiaoqi Wei, Wendi Wang, et al.
(2025)
Closed Access
Xinyi Fan, Xiaoqi Wei, Wendi Wang, et al.
(2025)
Closed Access
Cardiac Regeneration in Adult Zebrafish: A Review of Signaling and Metabolic Coordination
Arkadeep Mitra, Subhadeep Mandal, Kalyan Banerjee, et al.
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
Arkadeep Mitra, Subhadeep Mandal, Kalyan Banerjee, et al.
Current Cardiology Reports (2025) Vol. 27, Iss. 1
Closed Access
Advances in the Development of Mitochondrial Pyruvate Carrier Inhibitors for Therapeutic Applications
Henry Politte, Lingaiah Maram, Bahaa Elgendy
Biomolecules (2025) Vol. 15, Iss. 2, pp. 223-223
Open Access
Henry Politte, Lingaiah Maram, Bahaa Elgendy
Biomolecules (2025) Vol. 15, Iss. 2, pp. 223-223
Open Access
Cardioprotective Effects of the Jiming Formula on Myocardial Metabolism in Mice with Myocardial Infarction via the AMPK/SIRT1/PGC-1α Pathway
Xinyi Fan, Xiaoqi Wei, Wendi Wang, et al.
Phytomedicine (2025), pp. 156727-156727
Closed Access
Xinyi Fan, Xiaoqi Wei, Wendi Wang, et al.
Phytomedicine (2025), pp. 156727-156727
Closed Access
Triketone-acylphloroglucinol-monoterpenoid hybrids from Callistemon viminalis, a new structural template of anti-cardiac hypertrophy
Qinghong Meng, Yanjie Huang, Long-Gao Xiao, et al.
Bioorganic Chemistry (2025) Vol. 161, pp. 108542-108542
Closed Access
Qinghong Meng, Yanjie Huang, Long-Gao Xiao, et al.
Bioorganic Chemistry (2025) Vol. 161, pp. 108542-108542
Closed Access
Oral Sulforaphane Intervention Protects Against Diabetic Cardiomyopathy in db/db Mice: Focus on Cardiac Lipotoxicity and Substrate Metabolism
Pan Wang, Ziling Wang, Xinyuan Jin, et al.
Antioxidants (2025) Vol. 14, Iss. 5, pp. 603-603
Open Access
Pan Wang, Ziling Wang, Xinyuan Jin, et al.
Antioxidants (2025) Vol. 14, Iss. 5, pp. 603-603
Open Access
Fibroblast-to-cardiomyocyte lactate shuttle modulates hypertensive cardiac remodelling
Tong Wei, Yuetong Guo, Chenglin Huang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Tong Wei, Yuetong Guo, Chenglin Huang, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Heart Failure and Drug Therapies: A Metabolic Review
Frank Yu, Bianca McLean, Mitesh Badiwala, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2960-2960
Open Access | Times Cited: 14
Frank Yu, Bianca McLean, Mitesh Badiwala, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 2960-2960
Open Access | Times Cited: 14
Novel targets for ameliorating energy metabolism disorders in depression through stable isotope-resolved metabolomics
Ting Linghu, Yun-hao Zhao, Wenze Wu, et al.
Biochimica et Biophysica Acta (BBA) - Bioenergetics (2022) Vol. 1863, Iss. 7, pp. 148578-148578
Open Access | Times Cited: 13
Ting Linghu, Yun-hao Zhao, Wenze Wu, et al.
Biochimica et Biophysica Acta (BBA) - Bioenergetics (2022) Vol. 1863, Iss. 7, pp. 148578-148578
Open Access | Times Cited: 13
Understanding How Heart Metabolic Derangement Shows Differential Stage Specificity for Heart Failure with Preserved and Reduced Ejection Fraction
Federico Ferro, Renza Spelat, Camilla Valente, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 969-969
Open Access | Times Cited: 12
Federico Ferro, Renza Spelat, Camilla Valente, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 969-969
Open Access | Times Cited: 12
Lysophosphatidic Acid-Mediated Inflammation at the Heart of Heart Failure
Rajesh Chaudhary, Tahra K. Suhan, Mahmud W. Tarhuni, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 3, pp. 113-120
Open Access | Times Cited: 2
Rajesh Chaudhary, Tahra K. Suhan, Mahmud W. Tarhuni, et al.
Current Cardiology Reports (2024) Vol. 26, Iss. 3, pp. 113-120
Open Access | Times Cited: 2
Energy metabolism homeostasis in cardiovascular diseases.
Lu-Yun Wang, Chen Chen
PubMed (2021) Vol. 18, Iss. 12, pp. 1044-1057
Closed Access | Times Cited: 12
Lu-Yun Wang, Chen Chen
PubMed (2021) Vol. 18, Iss. 12, pp. 1044-1057
Closed Access | Times Cited: 12